302 related articles for article (PubMed ID: 21179597)
1. Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.
Eftekhari S; Edvinsson L
Ther Adv Neurol Disord; 2010 Nov; 3(6):369-78. PubMed ID: 21179597
[TBL] [Abstract][Full Text] [Related]
2. CGRP receptor antagonism and migraine therapy.
Edvinsson L; Warfvinge K
Curr Protein Pept Sci; 2013 Aug; 14(5):386-92. PubMed ID: 23745702
[TBL] [Abstract][Full Text] [Related]
3. CGRP receptor antagonism and migraine.
Edvinsson L; Ho TW
Neurotherapeutics; 2010 Apr; 7(2):164-75. PubMed ID: 20430315
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level.
Eftekhari S; Edvinsson L
BMC Neurosci; 2011 Nov; 12():112. PubMed ID: 22074408
[TBL] [Abstract][Full Text] [Related]
7. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.
Eftekhari S; Salvatore CA; Calamari A; Kane SA; Tajti J; Edvinsson L
Neuroscience; 2010 Aug; 169(2):683-96. PubMed ID: 20472035
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
Durham PL; Vause CV
CNS Drugs; 2010 Jul; 24(7):539-48. PubMed ID: 20433208
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
Meßlinger K
Schmerz; 2020 Apr; 34(2):181-187. PubMed ID: 32103345
[TBL] [Abstract][Full Text] [Related]
10. [Neuropeptide effects on the trigeminal system: pathophysiology and clinical significance for migraine].
Messlinger K; Fischer MJ; Lennerz JK
Schmerz; 2011 Aug; 25(4):393-8, 400-1. PubMed ID: 21818718
[TBL] [Abstract][Full Text] [Related]
11. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier.
Eftekhari S; Salvatore CA; Johansson S; Chen TB; Zeng Z; Edvinsson L
Brain Res; 2015 Mar; 1600():93-109. PubMed ID: 25463029
[TBL] [Abstract][Full Text] [Related]
12. CGRP mechanism antagonists and migraine management.
Karsan N; Goadsby PJ
Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
[TBL] [Abstract][Full Text] [Related]
13. CGRP receptors in the control of pain and inflammation.
Benemei S; Nicoletti P; Capone JG; Geppetti P
Curr Opin Pharmacol; 2009 Feb; 9(1):9-14. PubMed ID: 19157980
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons.
Cornelison LE; Hawkins JL; Durham PL
Neuroscience; 2016 Dec; 339():491-501. PubMed ID: 27746346
[TBL] [Abstract][Full Text] [Related]
16. Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor.
Blumenfeld A; Durham PL; Feoktistov A; Hay DL; Russo AF; Turner I
Neurol Ther; 2021 Dec; 10(2):469-497. PubMed ID: 34076848
[TBL] [Abstract][Full Text] [Related]
17. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.
Edvinsson L
Br J Clin Pharmacol; 2015 Aug; 80(2):193-9. PubMed ID: 25731075
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class.
Hargreaves R; Olesen J
Headache; 2019 Jun; 59(6):951-970. PubMed ID: 31020659
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice.
Vilotti S; Vana N; Van den Maagdenberg AM; Nistri A
Neurosci Lett; 2016 May; 620():104-10. PubMed ID: 27021026
[TBL] [Abstract][Full Text] [Related]
20. Current understanding of trigeminal ganglion structure and function in headache.
Messlinger K; Russo AF
Cephalalgia; 2019 Nov; 39(13):1661-1674. PubMed ID: 29989427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
